Research and Development of Cellular Immunotherapy

Purpose of this Study

Researchers may collect health information from medical records and blood samples during routine or research visits. Some participants may provide larger blood samples or undergo a procedure called leukapheresis to collect white blood cells. These samples may be used to support future research and help develop personalized cell therapies.

Who Can Participate?

Eligibility

Participants may be able to join if they are adults ages 18 to 80 with cancer and can safely provide blood samples or undergo a procedure called apheresis to collect blood cells for research.

Age Range

18-80

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

Description

This study collects health information and samples such as blood, tissue, and other body fluids from people with cancer. Researchers will use or store these samples to help develop and improve cellular immunotherapies and other cancer treatments, with the goal of improving care for future patients.

Locations

Duke University Hospital
Other

Visit Timing

Weekdays

Compensation

No

Spanish Materials Available

No

Study Details

Full Title

Procurement and Use of Tumor, Blood and Other Specimens for Research and Development of Cellular Immunotherapy

Principal Investigator

Nicholas
Klemen

Protocol Number

PRO00120873

Enrollment Status

Pending Open to Enrollment